Main morphologic changes detected on bone marrow biopsy of patients before and during STI571 therapy
| Patients . | Cellularity . | Megakaryopoiesis . | Fibrosis . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | |
| Group 1 | |||||||||
| 1 SB | ↑↑↑ | ↑ | N | ↑↑ | N | N | 1 | 1 | 0 |
| 2 PM | ↑↑↑ | N | N | ↑ | N | N | 1 | 0 | 0 |
| 3 ZH | ↑↑↑ | ↑ | N | ↑↑ | ↑ | N | 3 | 1 | 0 |
| 4 UP | ↑↑↑ | N | N | ↑↑ | N | N | 1 | 0 | 0 |
| 5 SJ | ↑↑ | N | N | ↑ | N | ↑ | 1 | 0 | 0 |
| 6 PF | ↑ | N | N | N | N | N | 0 | 0 | 0 |
| 7 PE | ↑ | N | N | ↑ | N | N | 1 | 0 | 0 |
| 8 HJ | ↑↑↑ | ↑ | N | ↑ | ↑ | N | 0 | 0 | 0 |
| 9 HaJ | ↑↑↑ | ↑ | N | ↑ | N | N | 1 | 0 | 0 |
| Group 2 | |||||||||
| 1 HL | ↑↑↑ | N | ↑↑ | ↑↑ | N | ↑↑↑ | 2 | 1 | 1 |
| 2 UB | ↑↑↑ | ↑ | ↑↑↑ | ↑↑ | N | ↑ | 2 | 1 | 1 |
| 3 WH | ↑↑↑ | ↑↑ | N | ↓ | ↑ | N | 2 | 0 | 0 |
| 4 HR | ↑↑ | N | ↑ | N | N | ↑ | 1 | 0 | 0 |
| 5 ER | ↑↑↑ | ↑ | ↑ | ↑↑ | N | ↑ | 2 | 0 | 0 |
| 6 WA | ↑↑↑ | N | N | ↑↑ | N | N | 2 | 0 | 0 |
| 7 DA | ↑↑↑ | N | ↑ | ↑ | N | N | 1 | 0 | 0 |
| 8 KG | ↑↑↑ | ↑↑↑ | N | ↑↑ | ↑↑ | N | 2 | 1 | 0 |
| Group 3 | |||||||||
| 1 PH | ↑↑↑ | ↑↑↑ | ↑↑ | ↓↓ | ↓↓ | ↓ | 4 | 3 | 3 |
| 2 WF | ↑↑↑ | N | N | ↑↑↑ | N | N | 4 | 3 | 0 |
| 3 FM | ↑↑↑ | ↑ | ↑↑ | ↑↑ | N | ↑ | 3 | 0 | 0 |
| 4 TJ | ↑↑↑ | ↑ | ↑ | ↓↓ | N | N | 1 | 1 | 0 |
| 5 LK | ↑↑↑ | ↑↑↑ | ↑↑↑ | ↓↓ | ↓ | N | 0 | 0 | 0 |
| 6 GR | ↑↑↑ | ↑↑ | N | ↑↑ | ↑ | N | 2 | 1 | 1 |
| Patients . | Cellularity . | Megakaryopoiesis . | Fibrosis . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | |
| Group 1 | |||||||||
| 1 SB | ↑↑↑ | ↑ | N | ↑↑ | N | N | 1 | 1 | 0 |
| 2 PM | ↑↑↑ | N | N | ↑ | N | N | 1 | 0 | 0 |
| 3 ZH | ↑↑↑ | ↑ | N | ↑↑ | ↑ | N | 3 | 1 | 0 |
| 4 UP | ↑↑↑ | N | N | ↑↑ | N | N | 1 | 0 | 0 |
| 5 SJ | ↑↑ | N | N | ↑ | N | ↑ | 1 | 0 | 0 |
| 6 PF | ↑ | N | N | N | N | N | 0 | 0 | 0 |
| 7 PE | ↑ | N | N | ↑ | N | N | 1 | 0 | 0 |
| 8 HJ | ↑↑↑ | ↑ | N | ↑ | ↑ | N | 0 | 0 | 0 |
| 9 HaJ | ↑↑↑ | ↑ | N | ↑ | N | N | 1 | 0 | 0 |
| Group 2 | |||||||||
| 1 HL | ↑↑↑ | N | ↑↑ | ↑↑ | N | ↑↑↑ | 2 | 1 | 1 |
| 2 UB | ↑↑↑ | ↑ | ↑↑↑ | ↑↑ | N | ↑ | 2 | 1 | 1 |
| 3 WH | ↑↑↑ | ↑↑ | N | ↓ | ↑ | N | 2 | 0 | 0 |
| 4 HR | ↑↑ | N | ↑ | N | N | ↑ | 1 | 0 | 0 |
| 5 ER | ↑↑↑ | ↑ | ↑ | ↑↑ | N | ↑ | 2 | 0 | 0 |
| 6 WA | ↑↑↑ | N | N | ↑↑ | N | N | 2 | 0 | 0 |
| 7 DA | ↑↑↑ | N | ↑ | ↑ | N | N | 1 | 0 | 0 |
| 8 KG | ↑↑↑ | ↑↑↑ | N | ↑↑ | ↑↑ | N | 2 | 1 | 0 |
| Group 3 | |||||||||
| 1 PH | ↑↑↑ | ↑↑↑ | ↑↑ | ↓↓ | ↓↓ | ↓ | 4 | 3 | 3 |
| 2 WF | ↑↑↑ | N | N | ↑↑↑ | N | N | 4 | 3 | 0 |
| 3 FM | ↑↑↑ | ↑ | ↑↑ | ↑↑ | N | ↑ | 3 | 0 | 0 |
| 4 TJ | ↑↑↑ | ↑ | ↑ | ↓↓ | N | N | 1 | 1 | 0 |
| 5 LK | ↑↑↑ | ↑↑↑ | ↑↑↑ | ↓↓ | ↓ | N | 0 | 0 | 0 |
| 6 GR | ↑↑↑ | ↑↑ | N | ↑↑ | ↑ | N | 2 | 1 | 1 |
1 indicates bone marrow biopsy findings before STI571 treatment; 2, bone marrow biopsy findings after 6 weeks STI571 treatment; 3, bone marrow biopsy findings after 3-month STI571 treatment; ↑↑↑, highly increased; ↑↑, moderately increased; ↑, slightly increased; ↓↓↓, highly decreased; ↓↓, moderately decreased; ↓, slightly decreased; and N, normal.